This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Mint-Risperidon (2016-08-23)

Starting date:
August 23, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-60220

Affected Products

Mint-Risperidon

Reason

Out of specification result for an impurity during stability testing.

Depth of distribution

Pharmacies and Wholesalers - Canada (Ontario, Alberta, Saskatchewan, Quebec, British Columbia, Manitoba)

Affected products

Mint-Risperidon 

DIN, NPN, DIN-HIM
DIN 02359812
Dosage form

Tablet

Strength

1 mg

Lot or serial number

EOD035001

Companies
Recalling Firm
Mint Pharmaceuticals Inc.
1093 Meyerside Drive, Unit #1
Mississauga
L5T 1J6
Ontario
CANADA
Marketing Authorization Holder
Mint Pharmaceuticals Inc.
1093 Meyerside Drive, Unit #1
Mississauga
L5T 1J6
Ontario
CANADA

Date modified: